Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Federal Realty to Present at BofA Securities 2026 Global Real Estate
3+ day, 12+ hour ago (166+ words) NORTH BETHESDA, Md., Sept. 10, 2026 /PRNewswire/ -- Federal Realty Investment Trust announced today that the Company's management team is scheduled to participate in the BofA Securities 2026 Global Real Estate Conference on Wednesday, September 16, 2026 at 1:30 PM ET. Event: Federal Realty Presentation at the BofA…...
M/I Homes, Inc. Announces Third Quarter Webcast
3+ day, 16+ hour ago (92+ words) COLUMBUS, Ohio, Sept. 10, 2026 COLUMBUS, Ohio, Sept. 10, 2026 /PRNewswire/ -- M/I Homes, Inc. (NYSE:MHO) announces the following Webcast: M/I Homes, Inc. Announces Third Quarter Webcast October 21, 2026 @ 10:30AM Eastern Time How: Live over the Internet -- Simply log on to the web at…...
Designer Brands Inc. Reports Second Quarter of 2026 Financial Results
3+ day, 21+ hour ago (499+ words) Raising full year guidance following strong operating performance and positive start to third quarter Reduced total debt by $93.0 million compared to the second quarter last year COLUMBUS, Ohio, Sept. 10, 2026 /PRNewswire/ -- Designer Brands Inc. (DBI) (the "Company," "we," "us," "our," and…...
GROUPE DYNAMITE REPORTS STRONG SECOND QUARTER FISCAL 2026 RESULTS AS BRAND HEAT AND TOP-TIER LOCATIONS CONTINUE TO DRIVE GROWTH
3+ day, 21+ hour ago (848+ words) Sep 10, 2026, 07:00 ET MONTRÉAL, Sept. 10, 2026 /CNW/ -- Groupe Dynamite Inc. ("Groupe Dynamite" or the "Company") (TSX: GRGD) today reported its financial results for the fiscal year 2026's second quarter ended August 1, 2026. Fiscal 2026 Second Quarter Highlights Ratios and Recent Developments (1) Excludes any impact…...
SolarEdge to Webcast 2026 Investor Day Detailing Strategy, Roadmap and Financial Plans
3+ day, 21+ hour ago (87+ words) TradingView SolarEdge to Webcast 2026 Investor Day Detailing Strategy, Roadmap and Financial Plans SolarEdge announced it is webcasting its 2026 Investor Day to present strategy, product and technology roadmap, and operational and financial plans. - Investor Day webcast today at 10:00 AM ET with…...
Transcript: Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01
4+ day, 14+ hour ago (121+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Transcript: Beam Therapeutics Inc. Presents at Citigroup?s Biopharma…...
Transcript: Celcuity Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08
4+ day, 15+ hour ago (86+ words) marketscreener.com Transcript: Celcuity Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08:00 AM Published on 09/09/2026 at 12:51 pm EDT Good morning, everyone, and welcome to Citi's Back-to-School Biopharma Summit. I'm Eric Joseph, senior biotech analyst with the firm....
Businesses Achieved 322% ROI with Avalara, According to New Total Economic Impact Study
4+ day, 19+ hour ago (229+ words) New study finds a composite Avalara customer realized $1.2 million in benefits and $881,000 in net present value over three years, with payback in under six months To examine the potential return on investment that organizations may realize by deploying Avalara products…...
Transcript: Allogene Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 08
4+ day, 16+ hour ago (114+ words) marketscreener.com Every day, we give you free access to essential global business and financial news, through the work of our journalists and our partnerships with leading news and data providers. Transcript: Allogene Therapeutics, Inc. Presents at Citigroup?s Biopharma…...
Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development | SILO Stock News
4+ day, 19+ hour ago (213+ words) 50% off your first year of any Quiver subscription Silo Pharma will participate in the IPAC-RS Nasal Innovation Forum to discuss its novel PTSD treatment, SPC-15. Silo Pharma announced its participation in the IPAC-RS 2026 Nasal Innovation Forum in Jersey City, New…...